ABHD11 inhibition drives sterol metabolism to modulate T cell effector function and alleviate autoimmunity

Benjamin Jenkins(University of Cambridge), Nicholas Jones(Swansea University), Gareth W. Jones(University of Bristol), David Sumpton(Cancer Research UK), Ursula Fearon(Trinity College Dublin), Joanne Davies(Swansea University), James A. Nathan(University of Cambridge), Fernando M. Ponce-Garcia(Swansea University), Douglas J. Veale(St. Vincent's University Hospital), J. Cronin(Swansea University), Ardena Berisha(National University of Ireland, Maynooth), Johan Vande Voorde(Cancer Research UK Scotland Institute), David K. Finlay(Trinity College), Federico Bernuzzi(Cancer Research UK), Julianna Blagih(Université de Montréal), Benjamin F. Cravatt(Scripps Institution of Oceanography), Simon Eastham(University of Bristol), Andrew E. Hogan(National University of Ireland, Maynooth), Alexandra Howell(Institute of Infection and Immunity), Luke C. Davies(Swansea University), Yasmin R Jenkins(Swansea University), Chloe Moscrop(University of Bristol), Gonçalo Vale(The University of Texas Southwestern Medical Center), Emma E. Vincent(University of Bristol), Linda V. Sinclair(University of Dundee), Alejandro Huerta Uribe(University of Glasgow), James A. Pearson(Institute of Infection and Immunity), I PERRY(Swansea University), Micah J. Niphakis(San Diego Biomedical Research Institute), Matthew D. Hitchings(Swansea University), Jeffrey G. McDonald(The University of Texas Southwestern Medical Center)
bioRxiv (Cold Spring Harbor Laboratory)
March 19, 2025
Cited by 0


Related Papers